Tracey Technologies

Tracey Technologies manufactures the iTrace, a proprietary 5-in-1 ophthalmic diagnostic device that combines wavefront aberrometry, autorefraction, keratometry, pupillometry, and corneal topography into a single integrated system. The iTrace uses patented ray-tracing technology with 256 unique points of light to separately measure and visualize corneal and internal optical aberrations, enabling practitioners to objectively quantify visual function and diagnose sources of vision impairment. The device includes the iTrace Prime Dashboard, which calculates the Dysfunctional Lens Index (DLI), Corneal Performance Index (CPI), and Quality of Vision Index (QVI) to support clinical decision-making for premium intraocular lens (IOL) selection and surgical planning. Advanced software features include Toric Precision for toric IOL calculation and post-operative verification, IOL rotation assessment, and premium IOL conversion aids. The iTrace is used by ophthalmologists and optometrists in cataract evaluation, refractive surgery assessment, and second-opinion consultations. The company provides practice development support and training. The device is designed for office-based ophthalmic practices and supports improved surgical outcomes and patient satisfaction through objective visualization of corneal and lenticular contributions to visual quality.